{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T09:09:21Z","timestamp":1790932161885,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2009,5,7]],"date-time":"2009-05-07T00:00:00Z","timestamp":1241654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2009,5,7]],"date-time":"2009-05-07T00:00:00Z","timestamp":1241654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1038\/gt.2009.50","type":"journal-article","created":{"date-parts":[[2009,5,7]],"date-time":"2009-05-07T10:19:20Z","timestamp":1241691560000},"page":"973-981","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Subconjunctival gene delivery of the transcription factor GA-binding protein delays corneal neovascularization in a mouse model"],"prefix":"10.1038","volume":"16","author":[{"given":"K C","family":"Yoon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J A","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H J","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S K","family":"Im","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H J","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X H","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M Y","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J H","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S E","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K Y","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K K","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,5,7]]},"reference":[{"key":"BFgt200950_CR1","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1006\/exer.1999.0790","volume":"70","author":"A Kvanta","year":"2000","unstructured":"Kvanta A, Sarman S, Fagerholm P, Seregard S, Steen B . Expression of matrix metalloproteinase-2 and vascular endothelial growth factor in inflammation-associated corneal neovascularization. Exp Eye Res 2000; 70: 419\u2013428.","journal-title":"Exp Eye Res"},{"key":"BFgt200950_CR2","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1097\/00055735-200108000-00002","volume":"12","author":"JH Chang","year":"2001","unstructured":"Chang JH, Gabison EE, Kato T, Azar DT . Corneal neovascualrization. Curr Opin Ophthalmol 2001; 12: 242\u2013249.","journal-title":"Curr Opin Ophthalmol"},{"key":"BFgt200950_CR3","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.exer.2003.09.005","volume":"78","author":"E Gabison","year":"2004","unstructured":"Gabison E, Chang JH, Hernandez-Quintela E, Javier J, Lu PC, Ye H et al. Anti-angiogenic role of angiostatin during corneal wound healing. Exp Eye Res 2004; 78: 579\u2013589.","journal-title":"Exp Eye Res"},{"key":"BFgt200950_CR4","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/nm0195-27","volume":"1","author":"J Folkman","year":"1995","unstructured":"Folkman J . Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995; 1: 27\u201331.","journal-title":"Nat Med"},{"key":"BFgt200950_CR5","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/sj.gt.3301695","volume":"9","author":"YK Lai","year":"2002","unstructured":"Lai YK, Shen WY, Brankov M, Lai CM, Constable IJ, Rakoczy PE . Potential long-term inhibition of ocular neovascularisation by recombinant adeno-associated virus-mediated secretion gene therapy. Gene Therapy 2002; 9: 804\u2013813.","journal-title":"Gene Therapy"},{"key":"BFgt200950_CR6","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1006\/exer.2002.2075","volume":"75","author":"CM Lai","year":"2002","unstructured":"Lai CM, Spilsbury K, Brankov M, Zaknich T, Rakoczy PE . Inhibition of corneal neovascularization by recombinant adenovirus mediated antisense VEGF RNA. Exp Eye Res 2002; 75: 625\u2013634.","journal-title":"Exp Eye Res"},{"key":"BFgt200950_CR7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2174\/156652307779940252","volume":"7","author":"PA Campochiaro","year":"2007","unstructured":"Campochiaro PA . Gene therapy for ocular neovascularization. Curr Gene Ther 2007; 7: 25\u201333.","journal-title":"Curr Gene Ther"},{"key":"BFgt200950_CR8","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jconrel.2007.05.041","volume":"124","author":"EA Klausner","year":"2007","unstructured":"Klausner EA, Peer D, Chapman RL, Multack RF, Andurkar SV . Corneal gene therapy. J Control Release 2007; 124: 107\u2013133.","journal-title":"J Control Release"},{"key":"BFgt200950_CR9","doi-asserted-by":"publisher","first-page":"23349","DOI":"10.1074\/jbc.274.33.23349","volume":"274","author":"F V\u00e1zquez","year":"1999","unstructured":"V\u00e1zquez F, Hastings G, Ortega MA, Lane TF, Oikemus S, Lombardo M et al. METH-1, a human ortholog of ADAMTS-1, and METH-2 are members of a new family of proteins with angio-inhibitory activity. J Biol Chem 1999; 274: 23349\u201323357.","journal-title":"J Biol Chem"},{"key":"BFgt200950_CR10","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1001\/archopht.120.8.1063","volume":"120","author":"BK Ambati","year":"2002","unstructured":"Ambati BK, Joussen AM, Ambati J, Moromizato Y, Guha C, Javaherian K et al. Angiostatin inhibits and regresses corneal neovascularization. Arch Ophthalmol 2002; 120: 1063\u20131068.","journal-title":"Arch Ophthalmol"},{"key":"BFgt200950_CR11","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s00417-002-0591-7","volume":"241","author":"PC Wu","year":"2003","unstructured":"Wu PC, Liu CC, Chen CH, Kou HK, Shen SC, Lu CY et al. Inhibition of experimental angiogenesis of cornea by somatostatin. Graefes Arch Clin Exp Ophthalmol 2003; 241: 63\u201369.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"BFgt200950_CR12","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1159\/000071171","volume":"35","author":"DH Ma","year":"2003","unstructured":"Ma DH, Zhang F, Shi W, Yao JY, Hsiao CH, Wu HC et al. Expression of tissue inhibitor of metalloproteinase-4 in normal human corneal cells and experimental corneal neovascularization. Ophthalmic Res 2003; 35: 199\u2013207.","journal-title":"Ophthalmic Res"},{"key":"BFgt200950_CR13","first-page":"2378","volume":"41","author":"A Shafiee","year":"2000","unstructured":"Shafiee A, Penn JS, Krutzsch HC, Inman JK, Roberts DD, Blake DA . Inhibition of retinal angiogenesis by peptides derived from thrombospondin-1. Invest Ophthalmol Vis Sci 2000; 41: 2378\u20132388.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFgt200950_CR14","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1167\/iovs.03-0882","volume":"45","author":"C Shao","year":"2004","unstructured":"Shao C, Sima J, Zhang SX, Jin J, Reinach P, Wang Z et al. Suppression of corneal neovascularization by PEDF release from human amniotic membranes. Invest Ophthalmol Vis Sci 2004; 45: 1758\u20131762.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFgt200950_CR15","first-page":"2498","volume":"40","author":"Z Due\u00f1as","year":"1999","unstructured":"Due\u00f1as Z, Torner L, Corbacho AM, Ochoa A, Guti\u00e9rrez-Ospina G, L\u00f3pez-Barrera F et al. Inhibition of rat corneal angiogenesis by 16-kDa prolactin and by endogenous prolactin-like molecules. Invest Ophthalmol Vis Sci 1999; 40: 2498\u20132505.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFgt200950_CR16","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/sj.gt.3302442","volume":"12","author":"KC Yoon","year":"2005","unstructured":"Yoon KC, Ahn KY, Lee JH, Chun BJ, Park SW, Seo MS et al. Lipid-mediated delivery of brain-specific angiogenesis inhibitor 1 gene reduces corneal neovascularization in an in vivo rabbit model. Gene Therapy 2005; 12: 617\u2013624.","journal-title":"Gene Therapy"},{"key":"BFgt200950_CR17","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.bcmd.2003.09.005","volume":"32","author":"AG Rosmarin","year":"2004","unstructured":"Rosmarin AG, Resendes KK, Yang Z, Mc Millan JN, Fleming SL . GA-binding protein transcription factor: a review of GABP as an integrator of intracellular signaling and protein\u2013protein interactions. Blood Cells Mol Dis 2004; 32: 143\u2013154.","journal-title":"Blood Cells Mol Dis"},{"key":"BFgt200950_CR18","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1126\/science.279.5353.1037","volume":"279","author":"AH Batchelor","year":"1998","unstructured":"Batchelor AH, Piper DE, de la Brousse FC, Mcknight SL, Wolberger C . The structure of GABPalpha\/beta: an ETS domain-ankyrin repeat heterodimer bound to DNA. Science 1998; 279: 1037\u20131041.","journal-title":"Science"},{"key":"BFgt200950_CR19","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1128\/MCB.22.7.2147-2158.2002","volume":"22","author":"L Hauck","year":"2002","unstructured":"Hauck L, Kaba RG, Lipp M, Dietz R, von Harsdorf R . Regulation of E2F1-dependent gene transcription and apoptosis by the ETS-related transcription factor GABP\u03b31. Mol Cell Biol 2002; 22: 2147\u20132158.","journal-title":"Mol Cell Biol"},{"key":"BFgt200950_CR20","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.gene.2004.09.031","volume":"344","author":"DA O'Leary","year":"2005","unstructured":"O'Leary DA, Koleski D, Kola I, Hertzog PJ, Ristevski S . Identification and expression analysis of alternative transcripts of the mouse GA-binding protein (Gabp) subunits alpha and beta1. Gene 2005; 344: 79\u201392.","journal-title":"Gene"},{"key":"BFgt200950_CR21","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.febslet.2005.12.086","volume":"580","author":"BC Jeong","year":"2006","unstructured":"Jeong BC, Kim MY, Lee JH, Kee HJ, Kho DH, Han KE et al. Brain-specific angiogenesis inhibitor 2 regulates VEGF through GABP that acts as a transcriptional repressor. FEBS Lett 2006; 580: 669\u2013676.","journal-title":"FEBS Lett"},{"key":"BFgt200950_CR22","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/ncb1548","volume":"9","author":"ZF Yang","year":"2007","unstructured":"Yang ZF, Mott S, Rosmarin AG . The Ets transcription factor GABP is required for cell-cycle progression. Nat Cell Biol 2007; 9: 339\u2013346.","journal-title":"Nat Cell Biol"},{"key":"BFgt200950_CR23","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1161\/01.RES.0000269779.10644.dc","volume":"100","author":"Y Okada","year":"2007","unstructured":"Okada Y, Yano K, Jin E, Funahashi N, Kitayama M, Doi T et al. A three-kilobase fragment of the human Robo4 promoter directs cell type-specific expression in endothelium. Circ Res 2007; 100: 1712\u20131722.","journal-title":"Circ Res"},{"key":"BFgt200950_CR24","doi-asserted-by":"publisher","first-page":"6373","DOI":"10.1073\/pnas.0408318102","volume":"102","author":"VM Bedell","year":"2005","unstructured":"Bedell VM, Yeo SY, Park KW, Chung J, Seth P, Shivalingappa V et al. Roundabout4 is essential for angiogenesis in vivo. Proc Natl Acad Sci USA 2005; 102: 6373\u20136378.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgt200950_CR25","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1096\/fj.04-1991fje","volume":"19","author":"S Suchting","year":"2005","unstructured":"Suchting S, Heal P, Tahtis K, Stewart LM, Bicknell R . Soluble Robo4 receptor inhibits in vivo angiogenesis and endothelial cell migration. FASEB J 2005; 19: 121\u2013123.","journal-title":"FASEB J"},{"key":"BFgt200950_CR26","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/nm1742","volume":"14","author":"CA Jones","year":"2008","unstructured":"Jones CA, London NR, Chen H, Park KW, Sauvaget D, Stockton RA et al. Robo4 stabilizes the vascular network by inhibiting pathologic angiogenesis and endothelial hyperpermeability. Nature Med 2008; 14: 448\u2013453.","journal-title":"Nature Med"},{"key":"BFgt200950_CR27","first-page":"1625","volume":"37","author":"BM Kenyon","year":"1996","unstructured":"Kenyon BM, Voest EE, Chen CC, Flynn E, Folkman J, D'Amato RJ . A model of angiogenesis in the mouse cornea. Invest Ophthalmol Vis Sci 1996; 37: 1625\u20131632.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFgt200950_CR28","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1034\/j.1600-0420.1999.770404.x","volume":"77","author":"T Demir","year":"1999","unstructured":"Demir T, Celiker UO, K\u00fckner A, Mogulko\u00e7 R, Celebi S, Celiker H . Effect of Octreotide on experimental corneal neovascularization. Acta Ophthalmol Scand 1999; 77: 386\u2013390.","journal-title":"Acta Ophthalmol Scand"},{"key":"BFgt200950_CR29","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1159\/000099252","volume":"92","author":"E Knop","year":"2007","unstructured":"Knop E, Knop N . Anatomy and immunology of the ocular surface. Chem Immunol Allergy 2007; 92: 36\u201349.","journal-title":"Chem Immunol Allergy"},{"key":"BFgt200950_CR30","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1038\/nature05249","volume":"443","author":"BK Ambati","year":"2006","unstructured":"Ambati BK, Nozaki M, Singh N, Takeda A, Jani PD, Suthar T et al. Corneal avascularity is due to soluble VEGF receptor-1. Nature 2006; 443: 993\u2013997.","journal-title":"Nature"},{"key":"BFgt200950_CR31","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1016\/S0002-9440(10)63267-1","volume":"165","author":"B Kim","year":"2004","unstructured":"Kim B, Tang Q, Biswas PS, Xu J, Schiffelers RM, Xie FY et al. Inhibition of ocular angiogenesis by siRNA targeting vascular endothelial growth factor pathway genes: therapeutic strategy for herpetic stromal keratitis. Am J Pathol 2004; 165: 2177\u20132185.","journal-title":"Am J Pathol"},{"key":"BFgt200950_CR32","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1097\/ICO.0b013e318160d019","volume":"27","author":"V Hurmeric","year":"2008","unstructured":"Hurmeric V, Mumcuoglu T, Erdurman C, Kurt B, Dagli O, Durukan AH . Effect of subconjunctival bevacizumab (Avastin) on experimental corneal neovascularization in guinea pigs. Cornea 2008; 27: 357\u2013362.","journal-title":"Cornea"},{"key":"BFgt200950_CR33","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1097\/ICO.0b013e31815cf67d","volume":"27","author":"TI Kim","year":"2008","unstructured":"Kim TI, Kim SW, Kim S, Kim T, Kim EK . Inhibition of experimental corneal neovascularization by using subconjunctival injection of bevacizumab (Avastin). Cornea 2008; 27: 349\u2013352.","journal-title":"Cornea"},{"issue":"6","key":"BFgt200950_CR34","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1111\/j.1755-3768.2008.01399.x","volume":"87","author":"In-Cheon You","year":"2009","unstructured":"You IC, Kang IS, Lee SH, Yoon KC . Therapeutic effect of subconjunctival injection of bevacizumab in the treatment of corneal noevascularization. Acta Ophthalmol 2009; 87 (in press).","journal-title":"Acta Ophthalmologica"},{"key":"BFgt200950_CR35","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1182\/blood-2008-01-135079","volume":"112","author":"Y Okada","year":"2008","unstructured":"Okada Y, Jin E, Nikolova-Krstevski V, Yano K, Liu J, Beeler D et al. A GABP-binding element in the Robo4 promoter is necessary for endothelial expression in vivo. Blood 2008; 112: 2336\u20132339.","journal-title":"Blood"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/gt200950.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt200950","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt200950.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T09:53:35Z","timestamp":1648547615000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/gt200950"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5,7]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["BFgt200950"],"URL":"https:\/\/doi.org\/10.1038\/gt.2009.50","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5,7]]},"assertion":[{"value":"26 January 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2009","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2009","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2009","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}